PPIDT00098
Drug Information
| Name | Gonadorelin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB00644 |
| Type | biotech |
| Indication | For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Powder, for solution | Intravenous; Subcutaneous |
.5 mg / vial
|
| Powder, for solution | Intravenous; Subcutaneous |
100 mcg / vial
|
| Powder, for solution | Intravenous; Subcutaneous |
500 mcg / vial
|
| Powder | Not applicable |
1 g/1g
|
| Spray | Nasal |
0.2 MG
|
| Spray | Nasal |
0.2 mg/0.1ml
|
| Injection, solution | Intravenous |
0.1 mg/ml
|
| Injection, powder, for solution | Parenteral |
|
| Injection, powder, for solution | Parenteral |
3.2 mg
|
| Powder, for solution | Intravenous; Subcutaneous |
3.2 mg / vial
|
| Powder, for solution | Intravenous; Subcutaneous |
0.8 mg / vial
|
| Liquid; powder, for solution | Intravenous; Subcutaneous |
|